396 related articles for article (PubMed ID: 17482132)
1. Mesenchymal stem cell features of Ewing tumors.
Tirode F; Laud-Duval K; Prieur A; Delorme B; Charbord P; Delattre O
Cancer Cell; 2007 May; 11(5):421-9. PubMed ID: 17482132
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.
Carrillo J; García-Aragoncillo E; Azorín D; Agra N; Sastre A; González-Mediero I; García-Miguel P; Pestaña A; Gallego S; Segura D; Alonso J
Clin Cancer Res; 2007 Apr; 13(8):2429-40. PubMed ID: 17438102
[TBL] [Abstract][Full Text] [Related]
3. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
4. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
5. Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines.
Szuhai K; Ijszenga M; Tanke HJ; Rosenberg C; Hogendoorn PC
Cancer Genet Cytogenet; 2006 Apr; 166(2):173-9. PubMed ID: 16631476
[TBL] [Abstract][Full Text] [Related]
6. DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets.
Staege MS; Hutter C; Neumann I; Foja S; Hattenhorst UE; Hansen G; Afar D; Burdach SE
Cancer Res; 2004 Nov; 64(22):8213-21. PubMed ID: 15548687
[TBL] [Abstract][Full Text] [Related]
7. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors.
Nishimori H; Sasaki Y; Yoshida K; Irifune H; Zembutsu H; Tanaka T; Aoyama T; Hosaka T; Kawaguchi S; Wada T; Hata J; Toguchida J; Nakamura Y; Tokino T
Oncogene; 2002 Nov; 21(54):8302-9. PubMed ID: 12447693
[TBL] [Abstract][Full Text] [Related]
8. The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cells.
Amsellem V; Kryszke MH; Hervy M; Subra F; Athman R; Leh H; Brachet-Ducos C; Auclair C
Exp Cell Res; 2005 Apr; 304(2):443-56. PubMed ID: 15748890
[TBL] [Abstract][Full Text] [Related]
9. Lack of matrix metalloproteinase (MMP)-1 and -3 expression in Ewing sarcoma may be due to loss of accessibility of the MMP regulatory element to the specific fusion protein in vivo.
Yabe H; Fukuma M; Urano F; Yoshida K; Kato S; Toyama Y; Hata J; Umezawa A
Biochem Biophys Res Commun; 2002 Apr; 293(1):61-71. PubMed ID: 12054564
[TBL] [Abstract][Full Text] [Related]
10. Context matters: the hen or egg problem in Ewing's sarcoma.
Kovar H
Semin Cancer Biol; 2005 Jun; 15(3):189-96. PubMed ID: 15826833
[TBL] [Abstract][Full Text] [Related]
11. The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors.
Avigad S; Cohen IJ; Zilberstein J; Liberzon E; Goshen Y; Ash S; Meller I; Kollender Y; Issakov J; Zaizov R; Yaniv I
Cancer; 2004 Mar; 100(5):1053-8. PubMed ID: 14983502
[TBL] [Abstract][Full Text] [Related]
12. EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin.
Siligan C; Ban J; Bachmaier R; Spahn L; Kreppel M; Schaefer KL; Poremba C; Aryee DN; Kovar H
Oncogene; 2005 Apr; 24(15):2512-24. PubMed ID: 15735734
[TBL] [Abstract][Full Text] [Related]
13. The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology.
Szuhai K; Ijszenga M; de Jong D; Karseladze A; Tanke HJ; Hogendoorn PC
Clin Cancer Res; 2009 Apr; 15(7):2259-68. PubMed ID: 19318479
[TBL] [Abstract][Full Text] [Related]
14. Expression and regulation of the transcriptional repressor ZNF43 in Ewing sarcoma cells.
González-Lamuño D; Loukili N; García-Fuentes M; Thomson TM
Pediatr Pathol Mol Med; 2002; 21(6):531-40. PubMed ID: 12537770
[TBL] [Abstract][Full Text] [Related]
15. SK-NEP-1 and Rh1 are Ewing family tumor lines.
Smith MA; Morton CL; Phelps D; Girtman K; Neale G; Houghton PJ
Pediatr Blood Cancer; 2008 Mar; 50(3):703-6. PubMed ID: 17154184
[TBL] [Abstract][Full Text] [Related]
16. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
17. Cleavage of the Ewing tumour-specific EWSR1-FLI1 mRNA by hammerhead ribozymes.
Hühn R; Staege MS; Hesse M; Liebig B; Burdach SE
Anticancer Res; 2009 Jun; 29(6):1901-8. PubMed ID: 19528446
[TBL] [Abstract][Full Text] [Related]
18. [Minimal metastatic and minimal residual disease in patients with Ewing tumors].
Zoubek A; Pfleiderer C; Ambros PF; Kronberger M; Dworzak MN; Gruber B; Luegmayer A; Windhager R; Fink FM; Urban C
Klin Padiatr; 1995; 207(4):242-7. PubMed ID: 7564161
[TBL] [Abstract][Full Text] [Related]
19. Decreased wild-type full-length Et-A and -B receptors in neuroblastoma and Ewing sarcoma cells.
Berry PA; Zhang YF; Carter ND; Jeffery S; Burchill SA
Med Pediatr Oncol; 2001 Jan; 36(1):142-6. PubMed ID: 11464869
[TBL] [Abstract][Full Text] [Related]
20. Procholecystokinin as marker of human Ewing sarcomas.
Reubi JC; Koefoed P; Hansen Tv; Stauffer E; Rauch D; Nielsen FC; Rehfeld JF
Clin Cancer Res; 2004 Aug; 10(16):5523-30. PubMed ID: 15328192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
